# A randomized, double-blind, placebo-controlled study of liraglutide 3 mg \[LIRA 3mg\] on weight, body composition, hormonal and metabolic parameters in women with obesity and polycystic ovary syndrome (PCOS)

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/a-randomized-double-blind-placebo-controlled-study-of-liraglutide-3-mg-lira-3mg/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Karen Elkind‐Hirsch,Neil Chappell,Donna Shaler,John Storment,Drake E. Bellanger |
| Citations | 4 |
| DOI | 10.21203/rs.3.rs-799341/v1 |
| Fields | Medicine |
| Open Access | true |
| OA Status | green |
| OA URL | https://www.researchsquare.com/article/rs-799341/latest.pdf |
| OpenAlex ID | https://openalex.org/W4213036401 |
| Type | preprint |
| Year | 2021 |

## Paper authors

- [Donna Shaler](https://scholariq.org/researchers/donna-shaler/)
- [John Storment](https://scholariq.org/researchers/john-storment/)

## Paper journal

- [Research Square](https://scholariq.org/journals/research-square/)

## Paper primary topic

- [Ovarian function and disorders](https://scholariq.org/topics/ovarian-function-and-disorders/)

## Paper topics

- [Ovarian function and disorders](https://scholariq.org/topics/ovarian-function-and-disorders/)
- [Pharmacology and Obesity Treatment](https://scholariq.org/topics/pharmacology-and-obesity-treatment/)
- [Diabetes Treatment and Management](https://scholariq.org/topics/diabetes-treatment-and-management/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.